Clinical Trial Update: Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery [Phase 2]

View source ↗

Summary

Phase 2 study of GSK2862277 in adults undergoing oesophagectomy was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• GSK2862277

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Injury, Acute and Respiratory Distress Syndrome, Adult | Phase 2 | Status: TERMINATED | Results posted: 2019-01-11